Medpace Holdings, Inc.
MEDP- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001668397
In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 18 sales; 703 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.
Key figures
- Market capClose on Nov 10, 2026
- $18.6B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $199.6M in total
- 18
- 13F holdersQ2 2026, −29 vs. previous quarter
- 703
- 13F valueReported value at the end of Q2 2026
- $13.1B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $2.53B
- +20.0% year over year
- Net income, FY2025
- $451.1M
- +11.6% year over year
- Free cash flow, FY2025
- $681.9M
- +19.2% year over year
- Revenue, Q3 FY2026
- $716.0M
- +8.5% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.38M
- Shares sold short
- Change
- −228.1K
- −14.2% vs. previous
- Days to cover
- 3.46
- At average daily volume
Superinvestors holding MEDP, Q2 2026
Go to the superinvestors tab2 superinvestors report holding Medpace Holdings, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Giverny Capital
François Rochon
4.6%
Medpace Holdings, Inc.'s share of the portfolio
- Shares
- 253,931
- Value
- $134.5M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Medpace Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 (view filing)6:24 PM ET | Oct 29 | 4 days | Ewald Stephen PGeneral Counsel & Corp. Secy. | SSale | −1.25K | $690.00 | −$859.0K | −6.1%19.1K after | |
| Oct 28, 2026 (view filing)4:23 PM ET | Oct 26-27 | 2 days | Burwig Susan EExec. VP, Operations | SSale | −20.0K | $677.00 | −$13.5M | −27.0%54.0K after | 2 lots |
| Oct 1, 2026 (view filing)5:43 PM ET | Sep 29-30 | 2 days | Troendle August J.President & CEO | SSale | −48.7K | $623.03 | −$30.3M | −12.6%338.2K after | 2 lots |
| Sep 29, 2026 (view filing)4:13 PM ET | Sep 25-28 | 4 days | Troendle August J.President & CEO | SSale | −2.56K | $620.10 | −$1.59M | −0.7%386.9K after | 2 lots |
| Sep 25, 2026 (view filing)4:22 PM ET | Sep 23-24 | 2 days | Troendle August J.President & CEO | SSale | −43.9K | $624.01 | −$27.4M | −10.1%389.5K after | 2 lots |
| Sep 23, 2026 (view filing)4:05 PM ET | Sep 21-22 | 2 days | Troendle August J.President & CEO | SSale | −70.9K | $626.62 | −$44.4M | −14.1%433.4K after | 2 lots |
| Sep 21, 2026 (view filing)4:23 PM ET | Sep 17 | 4 days | Troendle August J.President & CEO | SSale | −10.9K | $620.40 | −$6.75M | −2.1%504.3K after | |
| Sep 17, 2026 (view filing)4:39 PM ET | Sep 15-16 | 2 days | Troendle August J.President & CEO | SSale | −24.7K | $621.00 | −$15.4M | −4.6%515.2K after | 2 lots |
| Aug 31, 2026 (view filing)4:11 PM ET | Aug 27 | 4 days | Troendle August J.President & CEO | SSale | −650 | $620.27 | −$403.2K | −0.1%539.9K after | |
| Aug 28, 2026 (view filing)4:32 PM ET | Aug 26 | 2 days | Kraft Robert O.Director | SSale | −3.86K | $617.81 | −$2.38M | −80.2%955 after |
Top 10 13F holders, Q2 2026
See all 703 holdersThe largest institutional positions in Medpace Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,498,248 | $1.32B | 0.02% | +27,808+1.1% | Added |
| Price T Rowe Associates Inc | 2,069,677 | $1.10B | 0.11% | +1,780,170+614.9% | Added |
| AQR Capital Management LLC | 1,278,935 | $677.3M | 0.24% | −74,902−5.5% | Reduced |
| Vanguard Portfolio Management LLC | 1,133,357 | $600.2M | 0.03% | +11,668+1.0% | Added |
| Vanguard Capital Management LLC | 1,026,820 | $543.8M | 0.01% | +15,749+1.6% | Added |
| State Street Corp | 710,895 | $376.5M | 0.01% | +28,666+4.2% | Added |
| Geode Capital Management, LLC | 710,465 | $376.3M | 0.02% | −34,641−4.6% | Reduced |
| Wasatch Advisors Inc | 636,595 | $337.1M | 2.21% | −137,336−17.7% | Reduced |
| Invesco Ltd. | 579,241 | $306.8M | 0.02% | +1,667+0.3% | Added |
| Baillie Gifford & Co | 473,211 | $250.6M | 0.23% | −29,980−6.0% | Reduced |
Holders of 5% or more of MEDP
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Medpace Holdings, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Troendle August J. | 13D/A | 19.10%5.40M shares | −0.90 ppfrom 20.00% | Apr 21, 202113 filings | Sep 28, 2026 | SEC |
| Price T Rowe Associates Inc | 13G | 7.20%2.07M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
Politician trades
All politician trades in MEDP6 members of Congress reported 22 trades in Medpace Holdings, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| May 28, 2026 |  David J. Taylor House · OH | Buy | $1K-$15K |
| May 28, 2026 | David J. Taylor House · OH | Buy | $1K-$15K |
| Mar 6, 2026 | David J. Taylor House · OH | Buy | $1K-$15K |
| Feb 13, 2026 |  Gilbert Ray Cisneros, Jr. House · CA | Sell | $15K-$50K |
| Feb 2, 2026 | David J. Taylor House · OH | Sell | $1K-$15K |
House · OH · May 28, 2026
Buy$1K-$15K
House · OH · May 28, 2026
Buy$1K-$15K
House · OH · Mar 6, 2026
Buy$1K-$15K
House · CA · Feb 13, 2026
Sell$15K-$50K
House · OH · Feb 2, 2026
Sell$1K-$15K